BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37580229)

  • 1. Gender differences in change of metabolic syndrome status and its components on all-cause and cause-specific mortalities: Over a decade follow-up study.
    Afaghi S; Esmaeili F; Azizi F; Hadaegh F
    Nutr Metab Cardiovasc Dis; 2023 Nov; 33(11):2128-2140. PubMed ID: 37580229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
    Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
    Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis.
    Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting heart rate is associated with the risk of metabolic syndrome and its components among Dong adults in southwest China: Cross-sectional findings of the China Multi-Ethnic Cohort Study.
    Zhang X; Hong F; Qin Z; Liu L; Yang J; Tang X; Li X; Zhang J; Luo P
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3475. PubMed ID: 34036712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects].
    Guize L; Thomas F; Pannier B; Bean K; Danchin N; Bénétos A
    Bull Acad Natl Med; 2006 Mar; 190(3):685-97; discussion 697-700. PubMed ID: 17140103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in the impact of metabolic syndrome components on mortality in older people: A systematic review and meta-analysis.
    Sergi G; Dianin M; Bertocco A; Zanforlini BM; Curreri C; Mazzochin M; Simons LA; Manzato E; Trevisan C
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1452-1464. PubMed ID: 32600955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.
    Wang J; Sarnola K; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Atherosclerosis; 2010 May; 210(1):237-42. PubMed ID: 19945701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting heart rate is associated with metabolic syndrome and predicted 10-year risk of cardiovascular disease: a cross-sectional study.
    Wu X; Du R; Hu C; Cheng D; Ma L; Li M; Xu Y; Xu M; Chen Y; Li D; Bi Y; Wang W; Ning G; Lu J
    J Diabetes; 2019 Nov; 11(11):884-894. PubMed ID: 30941862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
    Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
    Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
    Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
    BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study.
    Zabetian A; Hadaegh F; Sarbakhsh P; Azizi F
    BMC Public Health; 2009 May; 9():138. PubMed ID: 19435528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Ukena C; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Marx N; Weber MA; Williams B; Yusuf S
    Eur Heart J; 2020 Jan; 41(2):231-238. PubMed ID: 30590564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study.
    He D; Zhang X; Chen S; Dai C; Wu Q; Zhou Y; Jin Z; Wu S; Zhu Y
    Front Cardiovasc Med; 2021; 8():706999. PubMed ID: 34422932
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.